Biocon net down 42% quarterly, 17% yearly

Published On 2020-05-15 15:15 GMT   |   Update On 2020-05-16 06:03 GMT

Bengaluru, May 15 (IANS) Leading biotechnology firm Biocon reported Rs 123 crore consolidated net profit for the fourth quarter (Q4) of fiscal 2019-20, registering a 42 per cent annual decline from Rs 214 crore posted in the same period a year ago.

"Consolidated net profit for the fiscal 2019-20 also declined 17 per cent to Rs 748 crore from Rs 905 crore in the previous fiscal (2018-19)," said the city-based company in a regulatory filing on the BSE on Friday.

Consolidate revenue from operations for the quarter (Q4) under review, however, grew 3 per cent annually to Rs 1,581 crore from Rs 1,529 crore in the like period a year ago.

"For the fiscal (FY2020), operational revenue increased 15 per cent to Rs 6,367 crore from Rs 5,514 crore in the previous fiscal," it added.

Earnings before interest, tax, depreciation and amortization of assets (Ebitda) for the quarter also declined 11 per cent to Rs 382 crore from Rs 431 crore a year ago, but increased 15 per cent annually for the fiscal to Rs 1,765 crore from Rs 1,538 crore a year ago.

--IANS

fb/vd

Tags:    
Article Source : IANS

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Disclaimer :- This story, apart from the heading, has not been edited by Medical Dialogues Team and is auto-generated from news agency feeds. Source: IANS

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News